Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-001772
Filing Date
2015-01-14
Accepted
2015-01-14 16:22:12
Documents
1
Period of Report
2015-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3956
  Complete submission text file 0001140361-15-001772.txt   5545
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1905 W VALLEY VISTA DR CASTLE ROCK CO 80104
Business Address
MCGONEGAL JEFFREY (Reporting) CIK: 0001187604 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 15527443